Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research shows aspirin therapy didn’t work in almost half of stroke patients studied

21.07.2004


Northwestern Memorial research shows an aspirin a day may not keep strokes away

Northwestern Memorial researchers have found that nearly half of patients who suffered a stroke or transient ischemic attack (TIA) after having been committed to aspirin therapy were "aspirin resistant," meaning the aspirin wasn’t producing the antiplatelet (blood-thinning) effect needed to avoid these health threats. Aspirin resistance increased when patients had been taking baby (81 mg) or enteric coated aspirin.

"Previous studies conducted at Northwestern Memorial Hospital showed the majority of patients taking low-dose or coated aspirin are not getting the desired antiplatelet effect," explains Mark J. Alberts, M.D., director of the stroke program at Northwestern Memorial Hospital. "Now, we’ve taken our research one step further and shown that aspirin resistance does, in fact, correlate with clinical events. Many patients who are committed to taking aspirin each day are still having strokes or transient ischemic attacks." Dr. Alberts recently presented these findings at the 5th World Stroke Congress in Vancouver, Canada.



"This study is significant because it gets researchers one step closer to determining how we can maximize the effectiveness of aspirin," adds Dr. Alberts. "The long-term goal of this line of research is to determine if we can better tailor the type and strength of aspirin to maximize its effects as an anti-clotting agent, which may require routine testing of antiplatelet effects for individual patients.

"The message for patients is clear: do not rely on taking aspirin alone for reducing the risk of stroke. There are tried and true methods that have been shown to reduce the risk of stroke, which include controlling your blood pressure and diabetes, stopping smoking, eating right and exercising."

Northwestern Memorial investigators collected data on 59 patients who came to the hospital with a stroke or TIA. They studied the chronic aspirin users, requiring that patients had been taking aspirin for at least three days prior to admission. Antiplatelet effects of aspirin were measured at the time of admission using a machine about the size of a coffee maker — called a PFA 100 — which can quickly, easily and reliably measures platelet function in response to aspirin.

  • 22 patients were taking a baby aspirin; 73% of this patient group had no antiplatelet effect
  • 37 patients were taking an adult aspirin; 32% of this patient group had no antiplatelet effect

Information about aspirin formulation was only available for 29 patients.

  • 18 patients were taking coated aspirin; 73% had no antiplatelet effect
  • 11 patients were taking uncoated aspirin; 39% had no antiplatelet effect

This study indicates that adult aspirin produces more blood-thinning results than baby and/or enteric coated aspirin. Results from a prior study suggested that older women were more likely to experience aspirin resistance.

A stroke or "brain attack" occurs when blood circulation to the brain becomes interrupted. The most common type of stroke, ischemic stroke, occurs when an artery narrows or a blood clot blocks blood flow in an artery supplying the brain. A clot can form because of sluggish blood flow through a vessel narrowed by fatty deposits. The goal of aspirin is to thin the blood, thereby reducing the risk of blood clots.

Stroke is the third leading cause of death in the United States. Each year, approximately 750,000 patients have a stroke and 165,000 of them die. Increasing age is a major risk factor for stroke, so as the population ages, strokes become even more common.

Co-authors include: Deborah Bergman, NP, Mary Soeding, RN, Richard Bernstein, M.D., Glenn Ramsey, M.D., and Paul Lindholm, M.D.

Patty Keiler | EurekAlert!
Further information:
http://www.nmh.org

More articles from Studies and Analyses:

nachricht Multi-year study finds 'hotspots' of ammonia over world's major agricultural areas
17.03.2017 | University of Maryland

nachricht Diabetes Drug May Improve Bone Fat-induced Defects of Fracture Healing
17.03.2017 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>